Bioinformatics, Computational Algorithms, Computer Graphics, Data science techniques, Python Programming
Position at Seagen
Seagen is a global, multi-product biotechnology company dedicated to developing and commercializing transformative cancer medicines. As the industry leader in antibody-drug conjugate (ADC) technology, we pioneered a new generation in the science of harnessing antibodies to deliver cell-killing agents directly to cancer cells. Seagen’s dedication to improving the lives of cancer patients goes beyond science, and we believe that every employee has a role in contributing to this mission. By working together with a shared dedication and diverse perspectives, we are able to reach our full potential and make a real difference in the world. Seagen is a fast-growing company and has an abundance of opportunities available for you to grow your career. Put your passion to work at Seagen and join us!
Summary:
We are seeking a highly motivated Senior Scientist to join the Bioinformatics team in the Clinical Biomarkers and Diagnostics group within Translational Sciences at Seagen. Our group seeks to understand the mechanism of novel therapeutics and identify patient selection strategies using diverse patient data from human clinical trials. A successful candidate should have demonstrated technical proficiency in data science and visualization and possess scientific acumen and curiosity to engage with the biology underlying our drug development efforts. This role requires independent thought and benefits from collaboration across multiple functional areas spanning from clinical development to early research.
This position will enable analysis of biomarker and other clinical data from ongoing clinical trials as well as explore our historical trial data and public datasets to accelerate future drug development at Seagen.
This is a hybrid position based in our offices in the Seattle area or South San Francisco.
Principal Responsibilities:
Required Qualifications:
Preferred Qualifications:
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs.